*To the Editor:* The Coronavirus disease 2019 (COVID-19) is caused by a recently discovered novel enveloped RNA beta-corona virus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 is highly contagious, and as of April 26, 2020, approximately 2,900,422 confirmed cases have been reported worldwide with 203,055 related deaths.

COVID-19 is diagnosed by real time reverse transcription polymerase chain reaction (RT-PCR) assay. However, the test has several limitations and a sensitivity of only 30--70% at initial presentation; additionally, a negative RT-PCR does not rule out COVID-19 \[[@CR1]\]. Chest radiographs (CXRs) and computed tomography (CT) have been widely used for evaluating COVID-19 patients. However, CXRs have low sensitivity (20%) and may appear normal during the early stage of the disease and therefore are not recommended as the 1st line imaging tool \[[@CR2]\].

Chest CT is now the widely accepted imaging tool for evaluating suspected or confirmed COVID-19 cases, as well as for monitoring therapeutic response and follow-up. When compared to RT-PCR, the reported sensitivity, specificity and accuracy of chest CT are 97%, 25% and 68% respectively, while the positive and negative predictive values are 65% and 83% respectively. Additionally, 60--93% of the patients can have positive CT findings much before the initial RT-PCR tests turn positive \[[@CR3]\].

COVID-19 disease in the pediatric population is mostly mild \[[@CR4]\], with the most common CT findings being unilateral or bilateral subpleural ground-glass opacities, and consolidations with surrounding halo sign \[[@CR5]\]. Additional findings include- peribronchial distribution of disease and bronchial wall thickening. As the disease progresses, the consolidations can extend diffusely giving a "white lung" appearance accompanied by air-bronchogram sign. During the recovery stage, following treatment, the consolidations reduce in size and density, having a ground glass appearance. Pleural effusion and lymphadenopathy are rare \[[@CR5]\].

Based on this clinical information, we felt the need to bring to the attention of the pediatric physicians and surgeons, especially those battling against confirmed COVID-19 cases, the potential of chest CT and the valuable information it can provide. We feel a combination of pathogen detection using RT-PCR and early chest CT including follow-up imaging should be incorporated into the protocol when managing symptomatic pediatric COVID-19 patients.
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